Presence of pharmacological inhibitors of the PI3K/PTEN/Akt and mTOR signalling pathways during cryopreservation and organotypic cultures of murine ovaries limits early primordial follicle depletion

被引:0
|
作者
Terren, C. [1 ]
Nisolle, M. [2 ]
Munaut, C. [1 ]
机构
[1] Univ Liege, Lab Tumor & Dev Biol, GIGA Canc, Liege, Belgium
[2] Univ Liege, Dept Obstet & Gynecol, Hop Citadelle, Liege, Belgium
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-444
引用
收藏
页码:65 / 66
页数:2
相关论文
共 12 条
  • [1] Presence of pharmacological inhibitors of the PI3K/PTEN/Akt and mTOR signalling pathways during cryopreservation and organotypic cultures of murine ovaries limits early primordial follicle depletion
    Terren, C.
    Nisolle, M.
    Munaut, C.
    HUMAN REPRODUCTION, 2021, 36 : 338 - 338
  • [2] Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture
    Carmen Terren
    Michelle Nisolle
    Carine Munaut
    Journal of Ovarian Research, 14
  • [3] Pharmacological inhibition of the PI3K/PTEN/Akt and mTOR signalling pathways limits follicle activation induced by ovarian cryopreservation and in vitro culture
    Terren, Carmen
    Nisolle, Michelle
    Munaut, Carine
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [4] INHIBITION OF THE PI3K/AKT/MTOR PATHWAY IN A MURINE MODEL ATTENUATES PRIMORDIAL FOLLICLE DEPLETION DURING GONADOTOXIC CHEMOTHERAPY.
    Goldman, K. N.
    Keefe, D. L.
    Arju, R.
    Duncan, F. E.
    Grifo, J.
    Schneider, R.
    FERTILITY AND STERILITY, 2015, 104 (03) : E249 - E249
  • [5] Pharmacological modulation of PI3K/PTEN/Akt/mTOR/ERK signaling pathways in ischemic injury: a mechanistic perspective
    Khan, Heena
    Singh, Aditi
    Singh, Yashvardhan
    Sharma, Diksha
    Dua, Kamal
    Grewal, Amarjot Kaur
    Singh, Thakur Gurjeet
    METABOLIC BRAIN DISEASE, 2025, 40 (03)
  • [6] Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing
    Maidarti, Mila
    Anderson, Richard A.
    Telfer, Evelyn E.
    CELLS, 2020, 9 (01)
  • [7] Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR Inhibitors
    Janku, Filip
    Hong, David S.
    Fu, Siqing
    Piha-Paul, Sarina A.
    Naing, Aung
    Falchook, Gerald S.
    Tsimberidou, Apostolia M.
    Stepanek, Vanda M.
    Moulder, Stacy L.
    Lee, J. Jack
    Luthra, Rajyalakshmi
    Zinner, Ralph G.
    Broaddus, Russell R.
    Wheler, Jennifer J.
    Kurzrock, Razelle
    CELL REPORTS, 2014, 6 (02): : 377 - 387
  • [8] Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells
    Jian Wang
    Xiaoye Lv
    Xiutian Guo
    Yanbo Dong
    Peipei Peng
    Fang Huang
    Peng Wang
    Haoqian Zhang
    Jianguang Zhou
    Youliang Wang
    Bo Wei
    Zeng-Fu Shang
    Shanhu Li
    Oncogenesis, 10
  • [9] Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells
    Wang, Jian
    Lv, Xiaoye
    Guo, Xiutian
    Dong, Yanbo
    Peng, Peipei
    Huang, Fang
    Wang, Peng
    Zhang, Haoqian
    Zhou, Jianguang
    Wang, Youliang
    Wei, Bo
    Shang, Zeng-Fu
    Li, Shanhu
    ONCOGENESIS, 2021, 10 (01)
  • [10] Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
    Chappell, William H.
    Steelman, Linda S.
    Long, Jacquelyn M.
    Kempf, Ruth C.
    Abrams, Stephen L.
    Franklin, Richard A.
    Baesecke, Joerg
    Stivala, Franca
    Donia, Marco
    Fagone, Paolo
    Malaponte, Graziella
    Mazzarino, Maria C.
    Nicoletti, Ferdinando
    Libra, Massimo
    Maksimovic-Ivanic, Danijela
    Mijatovic, Sanja
    Montalto, Giuseppe
    Cervello, Melchiorre
    Laidler, Piotr
    Milella, Michele
    Tafuri, Agostino
    Bonati, Antonio
    Evangelisti, Camilla
    Cocco, Lucio
    Martelli, Alberto M.
    McCubrey, James A.
    ONCOTARGET, 2011, 2 (03) : 135 - 164